Biopharmaceutical start-up BioAge Labs is developing a weight loss drug for older adults known as azelaprag, which is ...

Demand for Eli Lilly’s Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily ...

In fact, demand has been so high that it's been surpassing supply, forcing Lilly and rival Novo Nordisk to invest in ...

Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to ...

Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass index in a recent trial.

Indianapolis-based Eli Lilly and Co. is ramping up its campaign against imitations of its blockbuster appetite-suppressing drugs, seeking to put an end to a regulatory designation that has allowed ...

Eli Lilly said it will spend $1.8 billion to boost production in Ireland of its popular diabetes and weight-loss drugs, along with ingredients for its recently approved Alzheimer’s treatment, Kisunla.

and Eli Lilly (Zepbound) set a high bar, but the report disagrees, arguing that the up-and-coming obesity drugs will have better efficacy, convenience and tolerability. Learn more about the future of ...

Terns Pharmaceuticals this morning reported that its small molecule GLP-1 pill led to weight loss in a short Phase 1 study, ...

The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

It’s here, roughly 10 minutes from town, that US pharmaceutical giant Eli Lilly & Co. is making its latest push to slake the unprecedented demand for its blockbuster drugs, Mounjaro and Zepbound. The ...

A growing number of people with type 1 diabetes are becoming overweight or obese, in part because insulin can cause weight ...